These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33170819)

  • 41. [Effect of preparation PPSB on coagulation and hemostasis in hemophilia B patients].
    Tarasova LN; Sadkov SA; Porokhnenko SG
    Gematol Transfuziol; 1984 Aug; 29(8):22-4. PubMed ID: 6479558
    [No Abstract]   [Full Text] [Related]  

  • 42. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study.
    Atsou S; Furlan F; Duchemin J; Ellouze S; Sourdeau É; Launois A; Roussel-Robert V; Stieltjes N; Combe S; Fontenay M; Curis E; Jourdi G
    Eur J Pharmacol; 2021 Jan; 891():173764. PubMed ID: 33249076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factor XI promotes hemostasis in factor IX-deficient mice.
    Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D
    J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coagulation factor IX in normal and haemophilia B plasma.
    Somer JB; Castaldi PA
    Br J Haematol; 1970 Feb; 18(2):147-59. PubMed ID: 5439522
    [No Abstract]   [Full Text] [Related]  

  • 46. Congenital deficiency of plasma thromboplastin component (PTC-factor IX): report of 25 cases from 19 unrelated families.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jan; 30(1):17-9. PubMed ID: 6820363
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical progress in gene therapy: sustained partial correction of the bleeding disorder in patients suffering from severe hemophilia B.
    Vandendriessche T; Chuah MK
    Hum Gene Ther; 2012 Jan; 23(1):4-6. PubMed ID: 22149214
    [No Abstract]   [Full Text] [Related]  

  • 48. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Bottasso B; Simoni L; Rosenberg RD
    Blood; 1990 Dec; 76(12):2540-5. PubMed ID: 2265248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of hemophilia B with 15 nm filtered factor IX-LFB].
    Derlon A
    Presse Med; 1998 Apr; 27(15):740-1. PubMed ID: 9767918
    [No Abstract]   [Full Text] [Related]  

  • 50. Monitoring of modified factor VIII and IX products.
    Kitchen S; Gray E; Mertens K
    Haemophilia; 2014 May; 20 Suppl 4():36-42. PubMed ID: 24762273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prednisolone treatment induced temporary factor IX normalization in mild hemophilia B who required an epidural infiltration: A case report.
    Carrette M; Feugray G; Chamouni P; Le Cam Duchez V; Fretigny M; Barbay V; Billoir P
    Transfus Apher Sci; 2019 Aug; 58(4):512-514. PubMed ID: 31272859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
    Middleton SM; Bennett IH; Smith JK
    Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review.
    Franchini M; Santoro C; Coppola A
    Thromb Haemost; 2016 Jul; 116(1):201-3. PubMed ID: 27052668
    [No Abstract]   [Full Text] [Related]  

  • 54. Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.
    Zhang G; Shi Q; Fahs SA; Kuether EL; Walsh CE; Montgomery RR
    Blood; 2010 Aug; 116(8):1235-43. PubMed ID: 20445020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients.
    Santagostino E; Negrier C; Klamroth R; Tiede A; Pabinger-Fasching I; Voigt C; Jacobs I; Morfini M
    Blood; 2012 Sep; 120(12):2405-11. PubMed ID: 22859609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A simple analytic method of the activation mechanism of factor IX using Western blotting].
    Sakai T; Ohkubo Y; Tanaka I; Yamamoto K; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1987 Jan; 28(1):47-52. PubMed ID: 3573331
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical experiences with chromatographic DEAE adsorbed prothrombin complex for control of bleeding and multiple tooth extraction in hemophilia B patients.
    Onishi H; Izuchi K; Matsumoto T; Kato R; Kusunose K
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):513-6. PubMed ID: 5317288
    [No Abstract]   [Full Text] [Related]  

  • 58. Current concepts in diagnosis and management of hemophilia.
    Aledort LM
    Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410
    [No Abstract]   [Full Text] [Related]  

  • 59. Factor IX complex.
    Aronson DL
    Semin Thromb Hemost; 1979; 6(1):28-43. PubMed ID: 390713
    [No Abstract]   [Full Text] [Related]  

  • 60. The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the South-East of Scotland.
    Prowse CV; Cash JD
    Br J Haematol; 1981 Jan; 47(1):91-104. PubMed ID: 7437348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.